December 13, 2017

Lasa Supergenerics Q2FY18

Lasa Supergenerics Q2FY18

  1. Revenue up 10% at 64.5cr
  2. EBITDA down 16% at 12.9cr
  3. Margins down 610 bps at 20%
  4. PAT up 23% at 8.6cr
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)